Patent & Trade Mark
Attorneys
We are
Experts in Navigating IP in the Asia Pacific Region
Working with clients in
Thanks to many years of global experience, FB Rice has a network of trusted advisors in all key jurisdictions. We turn to those advisors when assisting our clients to promote their interests.

For specific information on our Asia Pacific capability, click here.
One door to South East Asia
For a seamless service for filing and prosecuting patent and trade mark applications in South East Asia, click here.
Rachel Hooke

Partner

Rachel Hooke
“The importance of innovation in the medical technology is growing and FB Rice is here to help our clients protect their investment in research.”
“The importance of innovation in the medical technology is growing and FB Rice is here to help our clients protect their investment in research.”
The Australian 25 Year Patent
Since 1998, Australia has had an extension of patent term (EoT) regime that allows for an extension of term of up to 5 years for pharmaceutical patents. This means that a patent may have a maximum 25 year term.
Since 1998, Australia has had an extension of patent term (EoT) regime that allows for an extension of term of up to 5 years for pharmaceutical patents. This means that a patent may have a maximum 25 year term.
01 April 2019
Chunky revisited
The recent acceptance of the trade mark CHUNKY in the USA for Campbell‘s CHUNKY soup provides an indication of the efforts needed to obtain registration of a word which has low inherent adaptation to distinguish.
The recent acceptance of the trade mark CHUNKY in the USA for Campbell‘s CHUNKY soup provides an indication of the efforts needed to obtain registration of a word which has low inherent adaptation to distinguish.
Brett Lunn

Managing Partner

Brett Lunn
Brett Lunn is managing partner of FB Rice, and one of Australia’s most experienced and pragmatic intellectual property (IP) specialists. Having moved largely to an advisory capacity in recent years, Brett specialises in providing strategic advice in the corporate sphere, advising a range of businesses from corporations and SMEs to start-ups and research institutions.  Brett has been recognised in Intellectual Asset Management’s World’s Leading Patent Practitioners, as boasting technical knowledge far broader than his polymer physics training would suggest.

 

Brett Lunn is managing partner of FB Rice, and one of Australia’s most experienced and pragmatic intellectual property (IP) specialists. Having moved largely to an advisory capacity in recent years, Brett specialises in providing strategic advice in the corporate sphere, advising a range of businesses from corporations and SMEs to start-ups and research institutions.  Brett has been recognised in Intellectual Asset Management’s World’s Leading Patent Practitioners, as boasting technical knowledge far broader than his polymer physics training would suggest.

 

01 August 2019
Andrew Gregory promoted to FB Rice Senior Associate
We are thrilled to announce the promotion of Andrew Gregory to Senior Associate.
We are thrilled to announce the promotion of Andrew Gregory to Senior Associate.
Interfering RNA (iRNA) is no interference to manner of manufacture in Australia
The Australian Patent Office (APO) has determined that claims directed to a composition comprising double-stranded RNA (so-called “interfering RNA” or “iRNA”) is a manner of manufacture (patent eligible subject matter) in accordance with Section 18(1)(a) of the Patents Act.
The Australian Patent Office (APO) has determined that claims directed to a composition comprising double-stranded RNA (so-called “interfering RNA” or “iRNA”) is a manner of manufacture (patent eligible subject matter) in accordance with Section 18(1)(a) of the Patents Act.